glucosamine/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
No detected effect on visual analogue scale pain intensity
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“There was no statistical difference between the two groups in scores on the visual analog scale at 30 days for resting (mean [SD] score placebo group 3.5 [2.7] vs 3.3 [2.4] glucosamine group, P = 0.66) or walking (5.1 [2.6] vs 5.3 [2.4], P = 0.69); there was also no difference at 60 days for resting (3.4 [2.5] vs 3.2 [2.5], P = 0.81) or walking (4.9 [2.2] vs 4.9 [2.8], P = 0.90).”
Quoted verbatim from Randomized, controlled trial of glucosamine for treating osteoarthritis of the knee.. - Study
- RCT
- Duration
- 2 months
- Dose
- glucosamine 500 mg three times daily (salt not stated in abstract)
- Population
- patients aged 34 to 81 being treated for osteoarthritis of the knee at a Veterans Affairs Medical Center; pain at rest and while walking, at 30 and 60 days
Randomized, controlled trial of glucosamine for treating osteoarthritis of the knee.2000PMID:10693368Permalink
Keep reading
- Everything the graph holds on glucosamine
- Every compound studied against Visual analogue scale pain intensity
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M4PE3VJ2ZG1K2EQ8P1WVRGGV